drugset
drugset / Trial / NCT05870618

Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children

NCT05870618 ↗

Phase 4 Unknown 480 enrolled Zhejiang Provincial Center for Disease Control and Prevention China National Biotec Group Company Limited · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

This study is to evaluate the immunogenicity and safety of DTaP or DT given in children aged 6 years.

Timeline

Start
2023-05
Primary completion
2023-12
Completion
2024-11

Drugs

EvaluationDrugModalityDoseRoute
Subject DT Vaccine — —
Subject DTaP Vaccine — —

Indications

vaccinia